Ce produit n'est pas destiné à diagnostiquer, traiter, guérir ou prévenir toute maladie. Ces déclarations n'ont pas été évaluées par la Food and Drug Administration.
Ces informations sont fournies à titre éducatif uniquement et ne remplacent pas un avis médical professionnel, un diagnostic ou un traitement. Consultez toujours votre professionnel de santé avant d'utiliser des plantes, surtout si vous êtes enceinte, allaitez, prenez des médicaments ou avez une condition médicale.
MM
Not CommonGénéré par IA
Morel Mushroom
Morchella esculenta
Médecine alimentaire nutritive dans les traditions amérindiennes du Nord-Amérique
Cette fiche a été compilée à partir de résumés PubMed (NIH) avec l'assistance d'une IA. Chaque affirmation factuelle est citée par un article PubMed réel (voir la liste des sources). Elle n'a pas encore été révisée par un humain — confirmez auprès d'un professionnel de santé avant utilisation.
Compilé à partir de 30 articles PubMed · modèle : gemma4:31b
Résumé
Morchella esculenta is an edible and medicinal mushroom known for its unique flavor and a wide range of bioactivities, including immunomodulatory and hepatoprotective effects [PMID:35940783, PMID:34524632].
Contexte
Morchella esculenta (L.) Pers. is a species of edible mushroom prized for its distinctive flavor and used as a food and flavoring material in soups and sauces [PMID:35940783, PMID:34524632].
Usages traditionnels
In traditional Chinese medicine, mushrooms have been used for centuries for medicinal properties; specifically, morels have been used in traditional medical systems against infertility, fatigue, cancer, muscular pain, cough, and cold [PMID:35940783, PMID:37824403].
Composés actifs
Active constituents include polysaccharides (such as beta-glucans, galactomannan, and chitin), proteins, protein hydrolysates, polyphenolic compounds, vitamins, steroids, minerals, and polynucleotides [PMID:35940783, PMID:34524632, PMID:37824403]. Polysaccharides typically consist of mannose, galactose, glucose, arabinose, and xylose [PMID:34524632, PMID:40425301].
Mécanisme d'action
Polysaccharides may exert immunomodulatory effects via the activation of nuclear factor-kappa B (NF-κB) and the TLR4-TRAF6-MAPKs-NF-κB cascade signaling pathway [PMID:40425301, PMID:37049647]. Anti-inflammatory effects are associated with NF-κB dephosphorylation, blockade of toll-like receptor-4, and inhibition of cyclooxygenase-2 (COX-2) and inducible nitric oxide synthase (iNOS) [PMID:40425301, PMID:36056976]. Hepatoprotective effects against NAFLD are linked to the activation of the AMPK/Sirt1 signaling pathway [PMID:39884630].
Preuves cliniques
Preuve DNon-alcoholic Fatty Liver Disease (NAFLD)
Polysaccharides (MCP) reduced hepatic and serum triglycerides and cholesterol, and ameliorated steatohepatitis and fibrosis in mice [PMID:39884630]. A fucose-specific lectin (MEP5) also normalized lipid profiles and reduced hepatic lipid accumulation in mice [PMID:41539791].
Preuve DType 2 Diabetes Mellitus
Polysaccharides (MEP) regulated hyperglycemia, hyperlipidemia, and improved insulin sensitivity in T2DM mice models [PMID:36276816].
Preuve DCancer (Breast and Colon)
Extracts of M. esculenta induced apoptosis in MCF-7 and SW-480 cell lines by increasing expression of Bax, caspase-3, caspase-7, and caspase-9 and downregulating Bcl-2 [PMID:39225882].
Preuve DCardiotoxicity
Bioactive extracts attenuated doxorubicin-induced oxidative stress and myocardial injury in vitro using H9C2 cells [PMID:35997093].
Preuve DNephrotoxicity
Aqueous-ethanolic extract of mycelium protected against cisplatin and gentamicin-induced acute renal toxicity in mice [PMID:18692113].
Sécurité et effets indésirables
Ingestion of uncooked morels is associated with gastrointestinal toxicity, including severe symptoms, shock, and reported fatalities [PMID:38483842, PMID:38912890]. A case-control study identified a strong association between raw morel consumption and gastrointestinal illness, with cooked morels posing less risk [PMID:38483842].
Synthèse des preuves
The current evidence is primarily based on in vitro studies and animal models (Level D) and narrative reviews (Level C). There is a lack of human clinical trials to prove safety and efficacy for medicinal uses [PMID:37824403].
Sources PubMed
1.PMID: 35940783 (2022) — Mycochemical profile and health-promoting effects of morel mushroom Morchella esculenta (L.) - A review. · Food research international (Ottawa, Ont.)
2.PMID: 34524632 (2021) — Recent Advances on Bioactive Ingredients of Morchella esculenta. · Applied biochemistry and biotechnology
3.PMID: 40905838 (2025) — A narrative review of toxicity after exposure to true morel (Morchella genus) and false morel (Gyromitra genus) mushroom ingestions. · Clinical toxicology (Philadelphia, Pa.)
4.PMID: 36713368 (2022) — Immune regulatory functions of biologically active proteins from edible fungi. · Frontiers in immunology
5.PMID: 11714352 (2001) — Mercaptan-capturing properties of mushrooms.
Sources gouvernementales
Aucune monographie gouvernementale directe n'est disponible pour cette plante. Le contenu ci-dessous est généré par IA et n'a pas été vérifié par rapport à une source gouvernementale faisant autorité. Utilisez les liens de recherche pour consulter les sources officielles avant de vous fier à ces informations.
Extracts showed protective effects against cadmium-induced reproductive damages in male rats [PMID:34378681].
· Journal of agricultural and food chemistry
6.PMID: 39884630 (2025) — Hepatoprotective effects of polysaccharide from Morchella esculenta are associated with activation of the AMPK/Sirt1 signaling pathway in mice with NAFLD. · International journal of biological macromolecules
7.PMID: 40425301 (2025) — Morchella esculenta polysaccharides: a functional food with potential immunomodulatory properties. · Natural product research
8.PMID: 35997093 (2022) — Bioactive Extract of Morel Mushroom, Morchella esculenta (Ascomycota) Attenuates Doxorubicin-Induced Oxidative Stress Leading to Myocardial Injury. · International journal of medicinal mushrooms
9.PMID: 37824403 (2023) — Food and Antioxidant Supplements with Therapeutic Properties of Morchella esculenta (Ascomycetes): A Review. · International journal of medicinal mushrooms
10.PMID: 34378681 (2021) — Ameliorative effects of morel mushroom (Morchella esculenta) against Cadmium-induced reproductive toxicity in adult male rats. · Brazilian journal of biology = Revista brasleira de biologia
11.PMID: 29896444 (2018) — Mushroom Poisoning Mimicking Painless Progressive Jaundice: A Case Report with Review of the Literature. · Cureus
12.PMID: 33682557 (2022) — Morel mushroom, Morchella from Kashmir Himalaya: a potential source of therapeutically useful bioactives that possess free radical scavenging, anti-inflammatory, and arthritic edema-inhibiting activities. · Drug and chemical toxicology
13.PMID: 37049647 (2023) — Microanalysis Characterization and Immunomodulatory Effect for Selenium-Enriched Polysaccharide from Morchella esculenta (L.) Pers. · Molecules (Basel, Switzerland)
14.PMID: 36056976 (2022) — Morchella esculenta polysaccharide attenuate obesity, inflammation and modulate gut microbiota. · AMB Express
15.PMID: 39225882 (2025) — Morchella conica, Morchella esculenta and Morchella delicosa Induce Apoptosis in Breast and Colon Cancer Cell Lines via Pro-apoptotic and Anti-apoptotic Regulation. · Chinese journal of integrative medicine
16.PMID: 36900632 (2023) — Antioxidative and Protective Effect of Morchella esculenta against Dextran Sulfate Sodium-Induced Alterations in Liver. · Foods (Basel, Switzerland)
18.PMID: 37614603 (2023) — Dazomet changes microbial communities and improves morel mushroom yield under continuous cropping. · Frontiers in microbiology
19.PMID: 41539791 (2026) — A novel Fucose-specific lectin from Morchella esculenta modulates gut-liver Axis to alleviate non-alcoholic fatty liver disease. · Food research international (Ottawa, Ont.)
20.PMID: 38483842 (2024) — Outbreak Linked to Morel Mushroom Exposure - Montana, 2023. · MMWR. Morbidity and mortality weekly report
21.PMID: 36553692 (2022) — The Flavor Profiles of Highland Barley Fermented with Different Mushroom Mycelium. · Foods (Basel, Switzerland)
22.PMID: 34146607 (2021) — The unique genome organization of two novel fusariviruses hosted by the true morel mushroom Morchella esculenta. · Virus research
23.PMID: 33800212 (2021) — Isolation, Characterization, and Medicinal Potential of Polysaccharides of Morchella esculenta. · Molecules (Basel, Switzerland)
24.PMID: 41225867 (2025) — Vegetable-Mushroom Rotation Increases Morel (Morchella esculenta L.) Yields by Improving Soil Micro-Environments and Enhancing Overall Soil Quality. · Plants (Basel, Switzerland)
25.PMID: 35699800 (2022) — Investigation of Morchella esculenta and Morchella conica for their antibacterial potential against methicillin-susceptible Staphylococcus aureus, methicillin-resistant Staphylococcus aureus and Streptococcus pyogenes. · Archives of microbiology
26.PMID: 38912890 (2024) — Severe morel mushroom poisonings in France - a nationwide French poison centres study 2010-2020. · Clinical toxicology (Philadelphia, Pa.)
27.PMID: 37108946 (2023) — Decline in Morel Production upon Continuous Cropping Is Related to Changes in Soil Mycobiome. · Journal of fungi (Basel, Switzerland)
28.PMID: 36749056 (2023) — Characterization of Secondary Metabolites from Mycelial Cultures of Black Morel Mushroom Morchella importuna (Ascomycota). · International journal of medicinal mushrooms
29.PMID: 36276816 (2022) — Morchella esculenta mushroom polysaccharide attenuates diabetes and modulates intestinal permeability and gut microbiota in a type 2 diabetic mice model. · Frontiers in nutrition
30.PMID: 18692113 (2008) — Aqueous-ethanolic extract of morel mushroom mycelium Morchella esculenta, protects cisplatin and gentamicin induced nephrotoxicity in mice. · Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association